Tai-Tsung Corp. (Stock Code: 4169), a player in the Biotechnology and Medical Care industry, has announced its March 2026 revenue. The company posted a monthly revenue of 61,779 thousand NTD (approximately NT$62 million), achieving a significant year-over-year growth of 9.1%.
FACT BOX
- Source: PR Times
- Category: News